DBV Technologies S.A. Insider Trading

DBVT

Last 12 months

Insiders sold 27K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Mar 2024.

Net open-market

−27K

0 buys · 3 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Mar 2024

Mar 8, 2024

Get an email when DBVT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 29	Pharis Mohideen Chief Medical Officer	SoldNo plan	464	$2.70	1K	0.3%	Form 4
Jan 29	Pharis Mohideen Chief Medical Officer	SoldNo plan	534	$4.86	3K	0.4%	Form 4
Dec 17, 2025 – Dec 18, 2025	Bpifrance Epic Other	SoldNo plan 3 parts	3,369,093	$4.60 average	$15.5M	31%	Form 4
Nov 20, 2025 – Nov 21, 2025	Pharis Mohideen Chief Medical Officer	SoldNo plan 2 parts	8,120	$2.86 average	23K	5.3%	Form 4
Jul 29, 2025	Pharis Mohideen Chief Medical Officer	SoldNo plan	464	$2.22	1K	0.4%	Form 4
May 22, 2025	Pharis Mohideen Chief Medical Officer	SoldNo plan	397	$1.84	$730	0.4%	Form 4
Jan 30, 2025	Pharis Mohideen Chief Medical Officer	SoldNo plan	600	$0.85	$510	0.5%	Form 4
Nov 22, 2024 – Nov 25, 2024	Pharis Mohideen Chief Medical Officer	SoldNo plan 2 parts	907	$0.55 average	$503	0.8%	Form 4
Nov 21, 2024	Pharis Mohideen Chief Medical Officer	SoldNo plan	2,350	$0.54	1K	2.1%	Form 4

Jul 29No plan
Pharis Mohideen
Chief Medical Officer · sold 464 at $2.70
1K
0.3% of stake
Jan 29No plan
Pharis Mohideen
Chief Medical Officer · sold 534 at $4.86
3K
0.4% of stake
Dec 17, 2025 – Dec 18, 2025No plan
Bpifrance Epic
Other · sold 3,369,093 at avg $4.60
$15.5M
31% of stake
Nov 20, 2025 – Nov 21, 2025No plan
Pharis Mohideen
Chief Medical Officer · sold 8,120 at avg $2.86
23K
5.3% of stake
Jul 29, 2025No plan
Pharis Mohideen
Chief Medical Officer · sold 464 at $2.22
1K
0.4% of stake
May 22, 2025No plan
Pharis Mohideen
Chief Medical Officer · sold 397 at $1.84
$730
0.4% of stake
Jan 30, 2025No plan
Pharis Mohideen
Chief Medical Officer · sold 600 at $0.85
$510
0.5% of stake
Nov 22, 2024 – Nov 25, 2024No plan
Pharis Mohideen
Chief Medical Officer · sold 907 at avg $0.55
$503
0.8% of stake
Nov 21, 2024No plan
Pharis Mohideen
Chief Medical Officer · sold 2,350 at $0.54
1K
2.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DBVT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with DBVT

CompareIntrinsic value

ALGSAligos Therapeutics Inc.

$5.02+5.68%10

DYAIDyadic International Inc.

$0.37+1.86%36

CRISCuris Inc.

$1.11+56.34%25

OCGNOcugen Inc.

$0.88+17.45%40

PRMEPrime Medicine Inc.

$4.97+9.23%0

HUMAHumacyte, Inc.

$0.45+2.04%10

TSHATaysha Gene Therapies Inc.

$4.36+6.60%40

OTLKOutlook Therapeutics Inc.

$0.46+0.46%10

Held by ETFs

DBVT is in 2 US ETFs. The largest of them, with DBVT's weight in each:

Spot a number that looks wrong? Check it in DBVT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DBVT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.